PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Regulatory News (GWP)

  • There is currently no data for GWP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Oct 2016 17:26

RNS Number : 5598N
GW Pharmaceuticals PLC
26 October 2016
 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Dr Geoffrey Guy

2.

Reason for the notification

a.

Position/status

Director/Chairman of the Board

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

GW Pharmaceuticals PLC

b.

LEI

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.1p each

ISIN: GB0030544687

b.

Nature of the transaction

Gift of Ordinary shares to family member - N.B. Price indicates closing market price on date of gift, nil proceeds were received for this gift

c.

Price(s) and volume(s)

 

Price(s)

 £8.12

Volume(s)

250,000

 

Ordinary shares gifted

d.

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.

Date of the transaction

25 October 2016

f.

Place of the transaction

 London 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFRISLRFIR
Date   Source Headline
13th Dec 20104:15 pmRNSDirector/PDMR Shareholding
9th Dec 20102:39 pmRNSPublication of Annual Report
8th Dec 20103:52 pmRNSDirector/PDMR Shareholding
3rd Dec 20107:00 amRNSChange of Adviser
29th Nov 20104:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20107:01 amRNSSativex Enters Phase III Cancer Pain Programme
23rd Nov 20107:00 amRNSFinal Results
19th Nov 201010:10 amRNSUpdate on Nomad and Broker Position
3rd Nov 20107:00 amRNSSativex Approved in New Zealand for MS Spasticity
21st Oct 201011:30 amRNSNotice of Results
21st Oct 201011:30 amRNSNotice of Results
14th Oct 20109:30 amRNSResearch Update
13th Oct 201012:12 pmRNSHolding(s) in Company
30th Sep 20107:03 amRNSGW Starts Phase IIa Study Programme
22nd Sep 20107:00 amRNSSativex Study Results Published in Peer Journal
16th Sep 20109:29 amRNSHolding(s) in Company
16th Sep 20109:28 amRNSHolding(s) in Company
14th Sep 20105:16 pmRNSDirector/PDMR Shareholding
9th Sep 201011:51 amRNSDirector/PDMR Shareholding
31st Aug 20107:00 amRNSHealth Canada Grants Full Approval of Sativex
3rd Aug 20107:00 amRNSDirector/PDMR Shareholding
28th Jul 20107:00 amRNSSativex receives regulatory authorisation in Spain
27th Jul 20107:00 amRNSDirectorate Change
23rd Jul 20105:10 pmRNSDirector/PDMR Shareholding
19th Jul 20103:33 pmRNSDirector/PDMR Shareholding
5th Jul 20105:35 pmRNSDirector/PDMR Shareholding
2nd Jul 201010:03 amRNSResponse to Media Comment
30th Jun 20107:00 amRNSGlobal Cannabinoid Research Collaboration Extended
22nd Jun 201011:23 amRNSGW Pharma to present at Piper Jaffray Conference
21st Jun 20107:00 amRNSUK Launch of First Prescription Cannabis-Medicine
18th Jun 20102:33 pmRNSProduct Update
11th Jun 20103:36 pmRNSDirector/PDMR Shareholding
20th May 20107:00 amRNSInterim Results
11th May 20104:21 pmRNSNotice of Results
28th Apr 20104:40 pmRNSSecond Price Monitoring Extn
28th Apr 20104:35 pmRNSPrice Monitoring Extension
31st Mar 20105:28 pmRNSTotal Voting Rights
25th Mar 20104:07 pmRNSDirector/PDMR Shareholding
24th Mar 20105:21 pmRNSHolding(s) in Company
24th Mar 20102:55 pmRNSResult of AGM
23rd Mar 20103:44 pmRNSHolding(s) in Company
23rd Mar 20103:38 pmRNSHolding(s) in Company
23rd Mar 20107:00 amRNSPositive Data in Sativex Phase IIb Trial
18th Mar 20107:00 amRNSSativex Regulatory Update
18th Jan 20105:27 pmRNSBlock Listing Application
15th Jan 201011:09 amRNSTotal Voting Rights
5th Jan 20104:35 pmRNSPrice Monitoring Extension
11th Dec 20098:57 amRNSDoc re. Annual Report
1st Dec 20097:00 amRNSChange of Adviser
26th Nov 20095:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.